Press coverage about UnitedHealth Group (NYSE:UNH) has trended positive this week, according to AlphaOne. The research firm, a subsidiary of Accern, ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. UnitedHealth Group earned a daily sentiment score of 0.44 on AlphaOne’s scale. AlphaOne also assigned news headlines about the healthcare conglomerate an impact score of 76 out of 100, meaning that recent media coverage is likely to have an effect on the stock’s share price in the near term.
These are some of the news headlines that may have impacted AlphaOne Sentiment’s scoring:
- Q2 2017 EPS Estimates for UnitedHealth Group Inc (UNH) Raised by Analyst (americanbankingnews.com)
- Q2 2017 EPS Estimates for UnitedHealth Group Inc Increased by Oppenheimer Holdings (UNH) (americanbankingnews.com)
- Credit Suisse Group AG Reiterates Outperform Rating for UnitedHealth Group Inc (UNH) (americanbankingnews.com)
- More Desired Stocks: UnitedHealth Group Incorporated (NYSE:UNH), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) – eMarketsDaily (emarketsdaily.com)
- UnitedHealth shuffles executives, names new UnitedHealthcare CEO (finance.yahoo.com)
UNH has been the subject of several analyst reports. Argus reaffirmed a “buy” rating and issued a $170.00 price objective on shares of UnitedHealth Group in a research note on Monday, January 23rd. Jefferies Group LLC reaffirmed a “buy” rating and issued a $186.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, January 10th. Barclays PLC reaffirmed a “buy” rating and issued a $187.00 price objective on shares of UnitedHealth Group in a research note on Monday, January 9th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $177.00 price objective for the company in a research note on Wednesday, February 22nd. Finally, Vetr lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 10th. One analyst has rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $181.05.
Shares of UnitedHealth Group (NYSE:UNH) traded up 1.35% on Thursday, hitting $171.54. The stock had a trading volume of 3,652,173 shares. The firm has a market cap of $163.16 billion, a price-to-earnings ratio of 23.66 and a beta of 0.68. The stock has a 50 day moving average of $167.08 and a 200 day moving average of $157.36. UnitedHealth Group has a 12-month low of $128.53 and a 12-month high of $172.19. UnitedHealth Group also saw unusually large options trading on Monday. Stock investors purchased 333 put options on the stock. This is an increase of approximately 200% compared to the typical daily volume of 111 put options.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.17 by $0.20. The company had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.81 earnings per share. Equities analysts predict that UnitedHealth Group will post $9.51 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 21st. Stockholders of record on Friday, March 10th were paid a dividend of $0.625 per share. The ex-dividend date of this dividend was Wednesday, March 8th. This represents a $2.50 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.47%.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Tuesday, February 14th. The shares were sold at an average price of $162.68, for a total transaction of $813,400.00. Following the completion of the sale, the director now owns 75,391 shares in the company, valued at $12,264,607.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 10,000 shares of the stock in a transaction dated Tuesday, January 31st. The stock was sold at an average price of $161.68, for a total transaction of $1,616,800.00. Following the sale, the director now owns 1,921,191 shares of the company’s stock, valued at approximately $310,618,160.88. The disclosure for this sale can be found here. Insiders have sold 35,310 shares of company stock valued at $5,855,416 in the last quarter. Insiders own 1.65% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally reported by WKRB News and is owned by of WKRB News. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at http://www.wkrb13.com/markets/2065565/unitedhealth-group-unh-getting-positive-press-coverage-analysis-shows.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065565/unitedhealth-group-unh-getting-positive-press-coverage-analysis-shows.html
Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.